RxDoctor Payments Data

William Hewitt, MD

Infectious Disease · Enterprise, ALNPI 1538229414

Payments from drug & device makers

$162in general payments, 2019–2025

Across 9 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$25
  • Lundbeck LLC$24
  • Medline Industries LP$19
  • Immedica Pharma US, Inc.$19
  • Axsome Therapeutics, Inc.$18
  • Octapharma USA, Inc.$17
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162 in reported general payments places this provider in the 25th percentile of 104 infectious disease providers in Alabama.

See all infectious disease providers in Alabama

Medicare billing

Part B allowed, 2024
$61,223
Medicare patients
211
Services billed
712

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Enterprise

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →